Stem Cell Manufacturing Industry Report 2024, Featuring Profiles of Anterogen, Becton, Dickinson and Company, Bio-Rad Laboratories, Cellular Dynamics International, Holostem Terapie Avanzate and More Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Manufacturing - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Stem Cell...

Stem Cell Therapy Strategic Business Report 2024 - Allogeneic Stem Cell Therapy Segment is Expected to Reach US$1 Billion by 2030 with a CAGR of a 16.7% Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Stem Cell Therapy was...

Cancer Stem Cells Market Projected to Reach $3.1 Billion by 2030, Fueled by Advances in Stem Cell Based Cancer Therapies Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The "Cancer Stem Cells Market Share, Size & Trends Analysis Report By Mode Of Action (Stem Cell based Cancer Therapy, Targeted CSCs), By Cancer Forms...

Stem Cell Technologies and Applications Market Report 2022-2032: Rise in Stem Cell Clinical Trials Bodes Well for Growth Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Stem Cell Technologies and Applications Market Report 2022-2032" report has been added to ResearchAndMarkets.com's offering.The Stem Cell Technologies...

Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions NEW YORK and MELBOURNE, Australia, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced that the United States Patent and Trademark Office (USPTO) has granted a...